Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Internal Medicine | Neurology | Nursing | Pharmacy | AIDS | Journal

Back to Journal Articles

Epilepsy, HIV Drug Combination Therapies Require Caution

Last Updated: January 05, 2012.

 

Coadministration of antiepileptic drugs and antiretrovirals may necessitate dose adjustment

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Antiepileptic drugs (AEDs) should be used with caution in individuals with HIV/AIDS, due to potential interactions between AEDs and antiretroviral agents, according to new guidelines issued by the American Academy of Neurology, published online Jan. 4 in Neurology.

THURSDAY, Jan. 5 (HealthDay News) -- Antiepileptic drugs (AEDs) should be used with caution in individuals with HIV/AIDS, due to potential interactions between AEDs and antiretroviral agents (ARVs), according to new guidelines issued by the American Academy of Neurology, published online Jan. 4 in Neurology.

Gretchen L. Birbeck, M.D., M.P.H., from Michigan State University in East Lansing, and colleagues reviewed available literature to develop guidelines for selecting AEDs for patients with HIV/AIDS.

The investigators found that up to 55 percent of patients taking ARVs may have an indication for AED-ARV combination therapy. For patients receiving both AEDs and ARVs, the guidelines offer drug-specific dosage changes for maintaining optimal serum concentrations. The guidelines also indicate when a dosage change may not be necessary for certain AED-ARV combinations, and recommend patients be counseled when the need for dose adjustment is unclear in their case. The researchers note that patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors should not be given enzyme-inducing AEDs; and when this cannot be avoided, the efficacy of the ARV regimen should be monitored.

"Future research regarding AED-ARV interactions is needed. Special priority should be given to the study of first-line AED-ARV combinations used in low and middle-income countries where second-line agents may not be available," the authors write.

Several of the study authors disclosed financial ties to the pharmaceutical and biotechnology industries.

Abstract
Full Text

Copyright © 2011 HealthDay. All rights reserved.


Previous: Prevalence of Sleep Problems Identified in Early Childhood Next: Vibratory Sense Unimpaired in Knee-Injured Patients

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.